Orrell, KG, Osborne, AG, Webba da Silva, Mateus, Hursthouseb, MB and Coles, SJ (1997) Preparation and characterisation of rhenium(I)and platinum(IV) complexes of 2,6-bis(pyrazol-lylmethyl)pyridine and 2,6=bis(3,5-dimethylpyrazol-1-ylmethyl)pyridine. Crystalstructure of fac-[ReI(CO),(BMPz)]. Polyhedron, 16 . pp. 3003-3017. [Journal article]
|PDF - Accepted Version |
Indefinitely restricted to Repository staff only.
Under mild conditions [ReX(CO),(THF),] reacts with pyrazolylmethylpyridines to form the complexesfat-[ReX(CO),(BPz)] and fat-[ReX(CO),(BMPz)] (X = Cl, Br, or I; BPz = 2,6-bis(pyrazol-l-ylmethyl)pyridine ; BMPz = 2,6-bis(3,5-dimethylpyrazol-1-ylmethyl)pyridine) that involve BPz and BMPz actingas non-fluxional bidentate chelate ligands. Under more severe reaction conditions fuc-[ReX(CO),(BPz)] isconverted to@-[Re(CO),(BPz)]X (X = Cl, Br, or I). Trimethylplatinum(IV)iodide reacts with BPz to formfuc-[PtMe,(BPz)]I. The crystal structure offac-[ReI(CO)3(BMPz)] confirms the bidentate chelate bonding ofBMPz with a N-Re-N angle of 85.8”.
|Item Type:||Journal article|
|Faculties and Schools:||Faculty of Life and Health Sciences|
Faculty of Life and Health Sciences > School of Pharmacy and Pharmaceutical Science
|Research Institutes and Groups:||Biomedical Sciences Research Institute|
Biomedical Sciences Research Institute > Molecular Medicine
Biomedical Sciences Research Institute > Molecular Medicine > Transcriptional Regulation & Epigenetics
|Deposited By:||Dr Mateus Webba da Silva|
|Deposited On:||03 May 2011 10:20|
|Last Modified:||04 Dec 2012 14:33|
Repository Staff Only: item control page